Life Sciences British Columbia (LSBC) is excited for the continued evolution of Invest in BC into Life Sciences Investment Week, from November 2-5, 2026. The week includes the main Invest in BC conference, now in its 11th year, and a slate of curated satellite events designed to foster meaningful connections. Invest in BC is presented by Lumira Ventures and will take place November 3-4, 2026, at the Vancouver Convention Centre West.
Life Sciences Investment Week is a cornerstone series of events for the province’s thriving life sciences sector. It brings together investors, entrepreneurs, researchers, and industry leaders for a week of high-impact networking, strategic partnering, and investment exploration. Whether attending to pitch, partner, or to invest in BC’s life sciences sector, participants will find unparalleled opportunities to connect and collaborate.
LSBC announces the companies selected to pitch at this year’s Invest in BC, which includes 25 companies from across Biotech, MedTech, and Health Tech / Digital Health.
Companies Selected to Pitch at the 2026 Invest in BC Conference
- 3C Therapeutics Inc.
- ARC Medical Inc.
- Avivo Biomedical Inc.
- Careteam
- Chondros Bio
- Eupraxia Pharmaceuticals
- Eyam Health Inc
- EyecareX
- GuideStar Medical Devices
- Haibu Health
- HTuO Biosciences
- Ikomed Technologies Inc.
- Incisive Genetics
- Integrated Nanotherapeutics
- Kapoose Creek Bio
- Omni Biotech Innovations Ltd.
- PrimeHealth
- Rakovina Therapeutics Inc.
- Resolve Nanotherapeutics
- Salvica Health
- Sustained Therapeutics
- Total Flow Medical
- Variational AI
- ViewsML
- VoxCell
Thank You to Our Supporters
Invest in BC is made possible by the generous support of these organizations:
- Presenting Sponsor: Lumira Ventures
- Conference Partner: Amplius Business Design
- Panel Sponsors: adMare BioInnovations, Mintz
- Keynote Sponsor: EY
- Pitch Session Sponsors: Genome British Columbia, Innovation UBC
- Technology Sponsor: AON
- Event Supporters: Berkley Canada; Canadian Alliance for Skills and Training in Life Sciences (CASTL); Osler, Hoskin & Harcourt LLP
Early Bird Conference and Partnering passes are available until October 2, 2026. For a full list of events and to secure your spot, learn more and register on our event page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260825781878/en/
Media gallery
